PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
12-Jan-2026 AbCellera Announces First Patients Dosed in Phase 2 Portion of its Phase 1/2 Clinical Trial of ABCL635 for the Treatment of Vasomotor Symptoms Due to Menopause Businesswire
12-Jan-2026 Lantern Pharma Announces Establishing an A.I. Center of Excellence in India to Industrialize the RADR® Platform and Accelerate Global Development Opportunities with BioPharma Companies Businesswire
12-Jan-2026 ZOLL LifeVest® WCD Saved 143 Lives Over the Holiday Season Businesswire
12-Jan-2026 Schrödinger Provides Update on Progress Across the Business and Outlines 2026 Strategic Priorities Businesswire
12-Jan-2026 Obsidian Therapeutics Appoints Julie Feder as Chief Financial Officer Businesswire
12-Jan-2026 NantWorks and ImmunityBio Announce Inaugural U.S.-Saudi Biotech Alliance Summit to Advance Immunotherapy 2.0 and Global Health Security Businesswire
12-Jan-2026 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
12-Jan-2026 Anumana Appoints Kevin Ballinger and Jean-Luc Butel to Board of Directors Businesswire
12-Jan-2026 Turn Therapeutics Announces Corporate and Pipeline Updates and 2026 Outlook Ahead of the 44th Annual J.P. Morgan Healthcare Conference Businesswire
12-Jan-2026 Harmony Biosciences Guides to Over $1 Billion in WAKIX® Revenue in 2026; Advancing Robust Late-Stage Pipeline With Potential for Long-term Value Creation Businesswire
12-Jan-2026 Junevity Announces First Peer-Reviewed Research Showing Single-Target Repression Can Reprogram Cellular Aging Businesswire
12-Jan-2026 Encoded Therapeutics Announces U.S. FDA Breakthrough Therapy Designation Granted to ETX101 for the Treatment of Dravet Syndrome Businesswire
12-Jan-2026 Kivu Bioscience Announces First Patient Dosed in Phase 1 Trial of KIVU-107 Next-Generation PTK7-Targeting ADC for Advanced Solid Tumors Businesswire
12-Jan-2026 Vir Biotechnology Provides Updates on Chronic Hepatitis Delta and Oncology Programs and Upcoming 2026 Clinical Milestones Businesswire
12-Jan-2026 U.S. FDA Grants RMAT Designation to ECT204, an ARTEMIS® CAR (AbTCR) T-Cell Therapy for Advanced Hepatocellular Carcinoma Businesswire
12-Jan-2026 Hummingbird Diagnostics Names Vincent Lozada Chief Executive Officer Businesswire
12-Jan-2026 Wilmington PharmaTech Appoints Seasoned Commercial Leader to Drive Growth Businesswire
12-Jan-2026 Atara Biotherapeutics Provides Regulatory and Business Update on EBVALLO™ (tabelecleucel) Businesswire
12-Jan-2026 PharmaEssentia Announces Positive Topline Phase 2b Data from EXCEED-ET Study Evaluating Ropeginterferon Alfa-2b-njft for Essential Thrombocythemia Businesswire
12-Jan-2026 IND Amendment Clearance Obtained for Clinical Manufacturing of Rese-Cel from Cabaletta Bio Using Cellares' Automated Platforms Businesswire